UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Hepatocellular Carcinoma with Portal Vein Tumor Involvement: Best Management Strategies

Seminars in liver disease, 2018-08, Vol.38 (3), p.242-251

2018

Volltextzugriff (PDF)

Harnessing the Power of Real‐World Evidence (RWE): A Checklist to Ensure Regulatory‐Grade Data Quality

Clinical pharmacology and therapeutics, 2018-02, Vol.103 (2), p.202-205

2018

Volltextzugriff (PDF)

Liver function changes after transarterial chemoembolization in US hepatocellular carcinoma patients: the LiverT study

BMC cancer, 2019-08, Vol.19 (1), p.795-795, Article 795

2019

Volltextzugriff (PDF)

Early‐onset pancreatic cancer research: Making sense of confounding and bias

Cancer, 2021-10, Vol.127 (19), p.3505-3507

2021

Volltextzugriff (PDF)

Real‐world progression, treatment, and survival outcomes during rapid adoption of immunotherapy for advanced non–small cell lung cancer

Cancer, 2019-11, Vol.125 (22), p.4019-4032

2019

Volltextzugriff (PDF)

Generating Real-World Tumor Burden Endpoints from Electronic Health Record Data: Comparison of RECIST, Radiology-Anchored, and Clinician-Anchored Approaches for Abstracting Real-World Progression in Non-Small Cell Lung Cancer

Advances in therapy, 2019-08, Vol.36 (8), p.2122-2136

2019

Volltextzugriff (PDF)

Induction Gemcitabine and Stereotactic Body Radiotherapy for Locally Advanced Nonmetastatic Pancreas Cancer

International journal of radiation oncology, biology, physics, 2011-11, Vol.81 (4), p.e615-e622

2011

Volltextzugriff (PDF)

Stereotactic Body Radiotherapy and Gemcitabine for Locally Advanced Pancreatic Cancer

International journal of radiation oncology, biology, physics, 2010-11, Vol.78 (3), p.735-742

2010

Volltextzugriff (PDF)

Small But Mighty: The Use of Real‐World Evidence to Inform Precision Medicine

Clinical pharmacology and therapeutics, 2019-07, Vol.106 (1), p.87-90

2019

Volltextzugriff (PDF)

Identification of prognostic biomarkers in hepatitis B virus-related hepatocellular carcinoma and stratification by integrative multi-omics analysis

Journal of hepatology, 2014-10, Vol.61 (4), p.840-849

2014

Volltextzugriff (PDF)

Real‐World Outcomes of Patients with Metastatic Non‐Small Cell Lung Cancer Treated with Programmed Cell Death Protein 1 Inhibitors in the Year Following U.S. Regulatory Approval

The oncologist (Dayton, Ohio), 2019-05, Vol.24 (5), p.648-656

2019

Volltextzugriff (PDF)

Lymph node metastases in resected pancreatic ductal adenocarcinoma: predictors of disease recurrence and survival

British journal of cancer, 2017-12, Vol.117 (12), p.1874-1882

2017

Volltextzugriff (PDF)

Emulating Control Arms for Cancer Clinical Trials Using External Cohorts Created From Electronic Health Record‐Derived Real‐World Data

Clinical pharmacology and therapeutics, 2022-01, Vol.111 (1), p.168-178

2022

Volltextzugriff (PDF)

Prospective Study of Bevacizumab Plus Temozolomide in Patients With Advanced Neuroendocrine Tumors

Journal of clinical oncology, 2012-08, Vol.30 (24), p.2963-2968

2012

Volltextzugriff (PDF)

Association between posttreatment α‐fetoprotein reduction and outcomes in real‐world US patients with advanced hepatocellular carcinoma

Cancer, 2023-07, Vol.129 (13), p.2064-2074

2023

Volltextzugriff (PDF)

Clinical Cancer Advances 2017: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology

Journal of clinical oncology, 2017-04, Vol.35 (12), p.1341-1367

2017

Volltextzugriff (PDF)

Does a statistically significant survival benefit of erlotinib plus gemcitabine for advanced pancreatic cancer translate into clinical significance and value?

Journal of clinical oncology, 2007-10, Vol.25 (28), p.4506-4507

2007

Volltextzugriff (PDF)

Efficacy and safety of cabozantinib for patients with advanced hepatocellular carcinoma based on albumin-bilirubin grade

British journal of cancer, 2022-03, Vol.126 (4), p.569-575

2022

Volltextzugriff (PDF)

Disparities in cardiovascular disease mortality after breast cancer treatment: Methodological considerations using real‐world data

Cancer, 2022-02, Vol.128 (4), p.647-650

2022

Volltextzugriff (PDF)

Future of Cancer Treatment Guidelines: Integrating Real-World Insights for Equitable Cancer Care

JCO clinical cancer informatics, 2024-06 (8)

2024

Volltextzugriff (PDF)

The US Food and Drug Administration Dual Mandate for Rapid Drug Review and Equity

JAMA network open, 2024-05, Vol.7 (5), p.e2411447-e2411447

2024

Volltextzugriff (PDF)

Telemedicine use among patients with metastatic breast cancer during the COVID‐19 pandemic: Differences by race, age, and region

Pharmacoepidemiology and drug safety, 2023-01, Vol.32 (1), p.66-72

2023

Volltextzugriff (PDF)

Priming of Sorafenib Prior to Radiofrequency Ablation Does Not Increase Treatment Effect in Hepatocellular Carcinoma

Digestive diseases and sciences, 2022-07, Vol.67 (7), p.3455-3463

2022

Volltextzugriff (PDF)

Impact of the COVID-19 Pandemic on Treatment Patterns for Patients With Metastatic Solid Cancer in the United States

JNCI : Journal of the National Cancer Institute, 2022-04, Vol.114 (4), p.571-578

2022

Volltextzugriff (PDF)

Efficacy, Safety, and Potential Biomarkers of Sunitinib Monotherapy in Advanced Hepatocellular Carcinoma: A Phase II Study

Journal of clinical oncology, 2009-06, Vol.27 (18), p.3027-3035

2009

Volltextzugriff (PDF)

1 – 25 von 142

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(134)
Mit Volltextzugriff
(119)

Publikationsform

Artikel
(140)
Berichte
(2)

Sprache

Englisch
(142)
Japanisch
(15)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Hepatocellular Carcinoma with Portal Vein Tumor Involvement: Best Management Strategies

Harnessing the Power of Real‐World Evidence (RWE): A Checklist to Ensure Regulatory‐Grade Data Quality

Liver function changes after transarterial chemoembolization in US hepatocellular carcinoma patients: the LiverT study

Early‐onset pancreatic cancer research: Making sense of confounding and bias

Real‐world progression, treatment, and survival outcomes during rapid adoption of immunotherapy for advanced non–small cell lung cancer

Generating Real-World Tumor Burden Endpoints from Electronic Health Record Data: Comparison of RECIST, Radiology-Anchored, and Clinician-Anchored Approaches for Abstracting Real-World Progression in Non-Small Cell Lung Cancer

Induction Gemcitabine and Stereotactic Body Radiotherapy for Locally Advanced Nonmetastatic Pancreas Cancer

Stereotactic Body Radiotherapy and Gemcitabine for Locally Advanced Pancreatic Cancer

Small But Mighty: The Use of Real‐World Evidence to Inform Precision Medicine

Identification of prognostic biomarkers in hepatitis B virus-related hepatocellular carcinoma and stratification by integrative multi-omics analysis

Real‐World Outcomes of Patients with Metastatic Non‐Small Cell Lung Cancer Treated with Programmed Cell Death Protein 1 Inhibitors in the Year Following U.S. Regulatory Approval

Lymph node metastases in resected pancreatic ductal adenocarcinoma: predictors of disease recurrence and survival

Emulating Control Arms for Cancer Clinical Trials Using External Cohorts Created From Electronic Health Record‐Derived Real‐World Data

Prospective Study of Bevacizumab Plus Temozolomide in Patients With Advanced Neuroendocrine Tumors

Association between posttreatment α‐fetoprotein reduction and outcomes in real‐world US patients with advanced hepatocellular carcinoma

Clinical Cancer Advances 2017: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology

Does a statistically significant survival benefit of erlotinib plus gemcitabine for advanced pancreatic cancer translate into clinical significance and value?

Efficacy and safety of cabozantinib for patients with advanced hepatocellular carcinoma based on albumin-bilirubin grade

Disparities in cardiovascular disease mortality after breast cancer treatment: Methodological considerations using real‐world data

Future of Cancer Treatment Guidelines: Integrating Real-World Insights for Equitable Cancer Care

The US Food and Drug Administration Dual Mandate for Rapid Drug Review and Equity

Telemedicine use among patients with metastatic breast cancer during the COVID‐19 pandemic: Differences by race, age, and region

Priming of Sorafenib Prior to Radiofrequency Ablation Does Not Increase Treatment Effect in Hepatocellular Carcinoma

Impact of the COVID-19 Pandemic on Treatment Patterns for Patients With Metastatic Solid Cancer in the United States

Efficacy, Safety, and Potential Biomarkers of Sunitinib Monotherapy in Advanced Hepatocellular Carcinoma: A Phase II Study

Suchergebnisse filtern